MORRIS PLAINS, N.J., Nov. 30, 2009 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that nine presentations involving its product candidates will be given at the 51st American Society of Hematology (ASH) Annual Meeting, scheduled for December 5 - 8, 2009, in New Orleans, LA. The schedule and meeting places for the presentations, together with the publication and board numbers are listed below:
